ARCHIVES

Waksal To Pay Back $800,000 In Profits From Stock Sales

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

November 21, 1975

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Alan Rabson Named Acting NCI Director

October 5, 2001

Society Develops Guidelines For Integrative Oncology

August 31, 2007

Radiology Program Has Accredited 1,200 Facilities

May 18, 1990

Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage

July 18, 2014